Skip to main content
CVE:NVH

Novoheart News Headlines

C$0.53
+0.01 (+1.92 %)
(As of 11/20/2020)
Add
Compare
Today's Range
C$0.52
C$0.53
50-Day Range
C$0.53
C$0.53
52-Week Range
C$0.26
C$0.72
Volume23,066 shs
Average Volume33,593 shs
Market CapitalizationC$99.98 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Novoheart (CVE NVH) News Headlines Today

SourceHeadline
Novoheart Holdings Inc. Enters into Definitive Agreements for Going-Private TransactionNovoheart Holdings Inc. Enters into Definitive Agreements for Going-Private Transaction
finance.yahoo.com - September 16 at 10:50 AM
Novoheart Holdings Inc. (NVH.V)Novoheart Holdings Inc. (NVH.V)
ca.finance.yahoo.com - August 16 at 8:41 AM
Novoheart Holdings Inc. Reports First Quarter 2020 Financial Results and Announces AGM ResultsNovoheart Holdings Inc. Reports First Quarter 2020 Financial Results and Announces AGM Results
www.bloomberg.com - May 21 at 7:46 PM
Novoheart Holdings Inc. Reports First Quarter 2019 Financial ResultsNovoheart Holdings Inc. Reports First Quarter 2019 Financial Results
www.bloomberg.com - May 20 at 11:19 PM
Were Keeping An Eye On Novoheart Holdingss (CVE:NVH) Cash Burn RateWe're Keeping An Eye On Novoheart Holdings's (CVE:NVH) Cash Burn Rate
finance.yahoo.com - May 19 at 12:13 PM
Does The Novoheart Holdings Inc. (CVE:NVH) Share Price Fall With The Market?Does The Novoheart Holdings Inc. (CVE:NVH) Share Price Fall With The Market?
finance.yahoo.com - April 4 at 5:16 PM
Novoheart Holdings Inc. Reports Second Quarter and Fiscal 2019 Financial ResultsNovoheart Holdings Inc. Reports Second Quarter and Fiscal 2019 Financial Results
www.globenewswire.com - March 11 at 6:45 PM
Novoheart Named 2020 Venture 50 Company, Ranked Among Year’s Top Performing Stocks in Life SciencesNovoheart Named 2020 Venture 50 Company, Ranked Among Year’s Top Performing Stocks in Life Sciences
www.globenewswire.com - February 20 at 1:29 PM
Novoheart Beats Faster on R&D Pact with Major PartnerNovoheart Beats Faster on R&D Pact with Major Partner
www.baystreet.ca - January 21 at 4:38 PM
Novoheart Quickens Pulses, Wins Another GrantNovoheart Quickens Pulses, Wins Another Grant
www.baystreet.ca - January 7 at 4:00 PM
Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening TechnologiesContinued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies
www.globenewswire.com - January 7 at 3:34 AM
Cineplex, CP, Novoheart Ride News at 52-Week HighsCineplex, CP, Novoheart Ride News at 52-Week Highs
www.baystreet.ca - December 16 at 1:39 PM
Novoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-JarNovoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-Jar
finance.yahoo.com - December 16 at 8:39 AM
Heres Why Were Not At All Concerned With Novoheart Holdingss (CVE:NVH) Cash Burn SituationHere's Why We're Not At All Concerned With Novoheart Holdings's (CVE:NVH) Cash Burn Situation
finance.yahoo.com - December 1 at 10:26 PM
Novoheart Announces Change of Fiscal Year-End and Grants Stock OptionsNovoheart Announces Change of Fiscal Year-End and Grants Stock Options
www.globenewswire.com - November 29 at 10:57 PM
Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZenecaNovoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca
www.marketwatch.com - November 26 at 9:22 AM
Novoheart Holdings Inc. Reports First Quarter 2020 Financial ResultsNovoheart Holdings Inc. Reports First Quarter 2020 Financial Results
www.marketwatch.com - November 20 at 12:29 AM
Two new Pfizer-coauthored studies validate Novoheart’s pioneering human bioengineered heart tissues and chambers for improving drug developmentTwo new Pfizer-coauthored studies validate Novoheart’s pioneering human bioengineered heart tissues and chambers for improving drug development
www.nasdaq.com - September 9 at 10:07 PM
Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2019 Financial ResultsNovoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2019 Financial Results
www.nasdaq.com - September 7 at 9:02 AM
Imagine Owning Novoheart Holdings (CVE:NVH) And Wondering If The 28% Share Price Slide Is JustifiedImagine Owning Novoheart Holdings (CVE:NVH) And Wondering If The 28% Share Price Slide Is Justified
finance.yahoo.com - July 26 at 4:16 PM
Novoheart Holdings Inc. Completes Acquisition of Xellera TherapeuticsNovoheart Holdings Inc. Completes Acquisition of Xellera Therapeutics
www.nasdaq.com - June 30 at 10:41 AM
Novoheart Announces Appointment of New Chief Financial OfficerNovoheart Announces Appointment of New Chief Financial Officer
www.nasdaq.com - June 17 at 3:52 PM
IIROC Trading Halt - NVHIIROC Trading Halt - NVH
markets.businessinsider.com - May 29 at 11:24 AM
Novoheart to Acquire Xellera TherapeuticsNovoheart to Acquire Xellera Therapeutics
www.nasdaq.com - May 29 at 11:24 AM
What Kind Of Shareholder Owns Most Novoheart Holdings Inc. (CVE:NVH) Stock?What Kind Of Shareholder Owns Most Novoheart Holdings Inc. (CVE:NVH) Stock?
finance.yahoo.com - May 23 at 11:49 AM
Novoheart Announces Revolving Credit FacilityNovoheart Announces Revolving Credit Facility
www.globenewswire.com - April 11 at 8:28 AM
Novoheart Holdings IncNovoheart Holdings Inc
www.bloomberg.com - March 18 at 4:04 PM
Novoheart Grants Stock OptionsNovoheart Grants Stock Options
globenewswire.com - March 7 at 12:43 PM
Novoheart Holdings Inc. Reports Second Quarter 2019 Financial Results and Announces AGM ResultsNovoheart Holdings Inc. Reports Second Quarter 2019 Financial Results and Announces AGM Results
www.marketwatch.com - March 2 at 11:23 AM
Novoheart Grants Stock Options and RSUsNovoheart Grants Stock Options and RSUs
globenewswire.com - February 9 at 10:52 AM
Novoheart Provides Corporate UpdateNovoheart Provides Corporate Update
globenewswire.com - January 8 at 11:14 AM
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.